Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK364735 Monotherapy in HIV-1
NCT00398125Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus type 1 infection (HIV-1) comparing GSK364735 with Placebo (2 arms). Primary endpoints: Change in viral load at Day 11 and Amount of drug in blood at Day 10. Started Nov 2006; status: completed.
02
Drugs
GSK-364735
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00398125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398125.